Global Brand Lead, Migraine
Ipsen, Cambridge, MA, United States
The
Global Brand Lead, Migraine
is responsible for defining and driving the global commercial strategy for Ipsen’s migraine franchise. The role's primary accountability is for the launch preparation of Dysport in chronic and episodic migraine and early brand strategy for IPN10200, Ipsen’s next-generation neuromodulator currently in Phase II development.
This role will establish migraine as a major new growth pillar for Ipsen, positioning Dysport to redefine the standard of care in episodic migraine and accelerate Ipsen’s expansion in the US and globally.
Working in close partnership with the Global Asset Lead, the Global Brand Lead serves as the global commercial architect of the migraine franchise, ensuring that development, evidence generation, market access, and commercialization strategies collectively support a differentiated value proposition versus leading migraine competitors.
The role requires understanding of the US migraine market, which represents the largest and most competitive market globally and the primary launch engine for the franchise. The leader will translate deep customer insights and competitive intelligence into global brand strategies that are scalable across priority markets including the US, EU5, and international regions.
Benchmarking against best-in-class migraine launches, the Global Brand Lead will build a high-impact launch platform capable of shaping treatment paradigms, driving guideline adoption, and establishing Ipsen as a long-term leader in migraine care. The position combines strategic leadership, launch excellence, and franchise building, with the ultimate goal of creating a sustainable, multi-asset migraine franchise delivering significant global revenue growth and meaningful patient impact.
WHAT - Main Responsibilities & Technical Competencies Global Migraine Franchise Strategy
Define and lead the global migraine franchise strategy, ensuring clear differentiation and long‑term value creation for Dysport migraine and IPN10200.
Shape the commercial vision for chronic and episodic migraine, identifying opportunities to redefine treatment paradigms and establish Ipsen as a leader in neuromodulator‑based migraine therapy.
Develop the Integrated Global Brand Plan aligned with the Integrated Asset Strategy led by the Therapeutic Lead.
Drive long‑term franchise planning, including lifecycle management, indication sequencing, and portfolio expansion opportunities.
Dysport Migraine – Global Launch Leadership
Lead global launch preparation for Dysport in migraine, ensuring a differentiated positioning versus established therapies and emerging competitors.
Define target patient segments, value proposition, and positioning strategy grounded in clinical differentiation and real‑world value.
Develop global launch playbooks, messaging frameworks, and commercialization models scalable across priority markets.
Partner with regions and affiliates to ensure US‑led launch excellence and global adaptation.
Drive launch readiness frameworks, KPIs, and performance dashboards to ensure execution excellence.
IPN10200 – Early Global Brand Strategy
Support the early commercial strategy for IPN10200, ensuring development decisions are informed by customer insights, market dynamics, and future value positioning.
Translate competitive insights into future brand differentiation and clinical value narratives.
Target product profile
Trial design and endpoints
Patient population prioritization
US Market Leadership & Competitive Positioning
Bring deep expertise in the US migraine ecosystem, including neurologists, headache specialists, integrated delivery networks, and payer environments.
Ensure the US market drives global strategy, while enabling adaptation for other regions.
Monitor and anticipate competitive moves
Shape strategies to ensure Ipsen competes effectively against market leaders.
External Engagement & Market Shaping
Build strong relationships with global migraine KOLs, headache societies, and advocacy groups.
Contribute to shaping the future treatment paradigm and clinical narrative in migraine.
Lead brand presence at major scientific congresses (AHS, EHF, AAN).
Performance & Franchise Growth
Define and track global migraine franchise KPIs.
Continuously optimize strategy based on real‑world insights, market feedback, and competitive dynamics.
HOW - Knowledge & Experience
15+ years of experience in the pharmaceutical or biotech industry.
Proven experience leading major product launches, particularly in the US market, including DTC campaigns
Strong expertise in migraine, neuroscience, or other large specialty markets with a consumer‑centric focus.
Demonstrated ability to build global brands with significant growth potential.
Good understanding of US healthcare ecosystem including payers, IDNs, and specialty care pathways.
Track record of leading cross‑functional teams in complex global organizations.
Several years of experience leading marketing and/or brand teams (including direct reports)
Experience in migraine launches or franchises (e.g., CGRP inhibitors, Gepants, neuromodulators) is an advantage
Experience competing in highly competitive, mass‑prevalence disease areas.
Experience working across US, EU, and international markets.
Able to work from our Cambridge, MA HQ on a flexible hybrid model
Able to travel domestically and internationally
Education / Certifications
BA/BS in Business, Economics, Life Sciences or related discipline is required
MBA or equivalent business qualification is preferred
English (fluent – spoken and written)
Language(s) (preferred)
Additional languages e.g., French or other a benefit
The annual base salary range for this position is $232,500 to $341,000
This job is eligible to participate in our short‑term incentives program. At Ipsen we are proud to offer a comprehensive employee benefits package, including 401(k) with company contributions, group medical, dental and vision coverage, life and disability insurance, short‑ and long‑term disability insurance, as well as flexible spending accounts. Ipsen also provides parental leave, paid time off, a discretionary winter shutdown, well‑being allowance, commuter benefits, and much more.
The pay range displayed above is the range of base pay compensation within which Ipsen expects to pay for this role at the time of this posting. Individual compensation within this range depends on a variety of factors, including, but not limited to, prior education and experience, job‑related knowledge and demonstrated skills.
#J-18808-Ljbffr
Global Brand Lead, Migraine
is responsible for defining and driving the global commercial strategy for Ipsen’s migraine franchise. The role's primary accountability is for the launch preparation of Dysport in chronic and episodic migraine and early brand strategy for IPN10200, Ipsen’s next-generation neuromodulator currently in Phase II development.
This role will establish migraine as a major new growth pillar for Ipsen, positioning Dysport to redefine the standard of care in episodic migraine and accelerate Ipsen’s expansion in the US and globally.
Working in close partnership with the Global Asset Lead, the Global Brand Lead serves as the global commercial architect of the migraine franchise, ensuring that development, evidence generation, market access, and commercialization strategies collectively support a differentiated value proposition versus leading migraine competitors.
The role requires understanding of the US migraine market, which represents the largest and most competitive market globally and the primary launch engine for the franchise. The leader will translate deep customer insights and competitive intelligence into global brand strategies that are scalable across priority markets including the US, EU5, and international regions.
Benchmarking against best-in-class migraine launches, the Global Brand Lead will build a high-impact launch platform capable of shaping treatment paradigms, driving guideline adoption, and establishing Ipsen as a long-term leader in migraine care. The position combines strategic leadership, launch excellence, and franchise building, with the ultimate goal of creating a sustainable, multi-asset migraine franchise delivering significant global revenue growth and meaningful patient impact.
WHAT - Main Responsibilities & Technical Competencies Global Migraine Franchise Strategy
Define and lead the global migraine franchise strategy, ensuring clear differentiation and long‑term value creation for Dysport migraine and IPN10200.
Shape the commercial vision for chronic and episodic migraine, identifying opportunities to redefine treatment paradigms and establish Ipsen as a leader in neuromodulator‑based migraine therapy.
Develop the Integrated Global Brand Plan aligned with the Integrated Asset Strategy led by the Therapeutic Lead.
Drive long‑term franchise planning, including lifecycle management, indication sequencing, and portfolio expansion opportunities.
Dysport Migraine – Global Launch Leadership
Lead global launch preparation for Dysport in migraine, ensuring a differentiated positioning versus established therapies and emerging competitors.
Define target patient segments, value proposition, and positioning strategy grounded in clinical differentiation and real‑world value.
Develop global launch playbooks, messaging frameworks, and commercialization models scalable across priority markets.
Partner with regions and affiliates to ensure US‑led launch excellence and global adaptation.
Drive launch readiness frameworks, KPIs, and performance dashboards to ensure execution excellence.
IPN10200 – Early Global Brand Strategy
Support the early commercial strategy for IPN10200, ensuring development decisions are informed by customer insights, market dynamics, and future value positioning.
Translate competitive insights into future brand differentiation and clinical value narratives.
Target product profile
Trial design and endpoints
Patient population prioritization
US Market Leadership & Competitive Positioning
Bring deep expertise in the US migraine ecosystem, including neurologists, headache specialists, integrated delivery networks, and payer environments.
Ensure the US market drives global strategy, while enabling adaptation for other regions.
Monitor and anticipate competitive moves
Shape strategies to ensure Ipsen competes effectively against market leaders.
External Engagement & Market Shaping
Build strong relationships with global migraine KOLs, headache societies, and advocacy groups.
Contribute to shaping the future treatment paradigm and clinical narrative in migraine.
Lead brand presence at major scientific congresses (AHS, EHF, AAN).
Performance & Franchise Growth
Define and track global migraine franchise KPIs.
Continuously optimize strategy based on real‑world insights, market feedback, and competitive dynamics.
HOW - Knowledge & Experience
15+ years of experience in the pharmaceutical or biotech industry.
Proven experience leading major product launches, particularly in the US market, including DTC campaigns
Strong expertise in migraine, neuroscience, or other large specialty markets with a consumer‑centric focus.
Demonstrated ability to build global brands with significant growth potential.
Good understanding of US healthcare ecosystem including payers, IDNs, and specialty care pathways.
Track record of leading cross‑functional teams in complex global organizations.
Several years of experience leading marketing and/or brand teams (including direct reports)
Experience in migraine launches or franchises (e.g., CGRP inhibitors, Gepants, neuromodulators) is an advantage
Experience competing in highly competitive, mass‑prevalence disease areas.
Experience working across US, EU, and international markets.
Able to work from our Cambridge, MA HQ on a flexible hybrid model
Able to travel domestically and internationally
Education / Certifications
BA/BS in Business, Economics, Life Sciences or related discipline is required
MBA or equivalent business qualification is preferred
English (fluent – spoken and written)
Language(s) (preferred)
Additional languages e.g., French or other a benefit
The annual base salary range for this position is $232,500 to $341,000
This job is eligible to participate in our short‑term incentives program. At Ipsen we are proud to offer a comprehensive employee benefits package, including 401(k) with company contributions, group medical, dental and vision coverage, life and disability insurance, short‑ and long‑term disability insurance, as well as flexible spending accounts. Ipsen also provides parental leave, paid time off, a discretionary winter shutdown, well‑being allowance, commuter benefits, and much more.
The pay range displayed above is the range of base pay compensation within which Ipsen expects to pay for this role at the time of this posting. Individual compensation within this range depends on a variety of factors, including, but not limited to, prior education and experience, job‑related knowledge and demonstrated skills.
#J-18808-Ljbffr